CDKN2B Antikörper (C-Term)
Kurzübersicht für CDKN2B Antikörper (C-Term) (ABIN1590129)
Target
Alle CDKN2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- p15INK4b (isoform 2)
-
Sequenz
- RQGARERGAR P
-
Spezifität
- This antibody is expected to recognize isoform 2 (NP_511042.1) only.
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western Blot: Approx 12+14 kDa bands observed in Human Gastrointestinal cancer lysates (calculated MW of 8.1 kDa according to NP_511042.1). The observed 14 kDa cannot represent isoform 1 and therefore it most likely represents another posttranslational modi
Peptide ELISA: antibody detection limit dilution 1:128000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Andere Bezeichnung
- CDKN2B
-
Hintergrund
- CDKN2B, cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), CDK4I, INK4B, MTS2, P15, TP15, p15INK4b, CDK inhibitory protein, CDK4B inhibitor, MTS-2, cyclin-dependent kinase 4 inhibitor B, cyclin-dependent kinases 4 and 6 binding protein, multiple t
-
Gen-ID
- 1030
-
NCBI Accession
- NP_004927, NP_511042
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
Target
-